A research-based biopharmaceutical company realized it was time to modernize the important paper inserts included in their prescription medication packages. The company aspired to migrate to electronic product information (ePI) to provide the most current information to its customers without wasting paper and ink. The brand needed an easy digital solution to implement into their packaging.
The respected pharmaceutical producer wanted to ensure that patients and healthcare professionals have the most recent, accessible, easy-to-read information about prescription medicines localized in the users’ native language. The biopharmaceutical company also wanted to transition from paper leaflets to a digital QR code to reduce paper and ink use and meet the European Commission’s Green Deal requirements, which is aimed at overcoming the challenges of climate change and environmental degradation.
The biopharmaceutical company chose Digimarc, a leading product digitization provider, to support the ePI effort by creating QR codes that patients and healthcare professionals can scan on the product packaging. The ePI’s product master data is stored in the Digimarc Illuminate platform, sending the right information to the right patients around the world. The codes are generated using the GS1 Digital Link standard and resolved through the Digimarc Illuminate platform, which routes users to the most updated ePI.
By implementing a QR code instead of printed leaflets, the biopharmaceutical company successfully improved access to the most current product information for patients and healthcare providers while reducing costs associated with product recalls and wasted drugs. The brand was also able to reduce paper and ink costs in countries where regulations permit the company to remove paper leaflets. Ultimately, the biopharmaceutical company is now closer to its goal of going completely paperless.
Share this Resource
